Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Henryschein Dental Company (NQ: HSIC )

69.88 +0.06 (+0.09%)
Streaming Delayed Price Updated: 12:17 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Henryschein Dental Company

< Previous 1 2 3 4 5 Next >
Dental Equipment & Technology Stocks Q4 Earnings Review: Align Technology (NASDAQ:ALGN) Shines
Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
3 Small-Cap Stocks Walking a Fine Line
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and... 
Via StockStory
Top S&P500 movers in Wednesday's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
Breaking Down Henry Schein: 7 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Is Henry Schein Gaining or Losing Market Support?
Via Benzinga
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth
Henry Schein Q4 sales grew 5.8% to $3.19 billion, missing estimates. The company was restructured into three segments. 
Via Benzinga
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q4 Earnings
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19... 
Via StockStory
Henry Schein (HSIC) Q4 Earnings Report Preview: What To Look For
Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know. 
Via StockStory
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
What Analysts Are Saying About Henry Schein Stock
Via Benzinga
How Is The Market Feeling About Henry Schein?
Via Benzinga
3 Reasons HSIC is Risky and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $77.62 per share while the index has gained... 
Via StockStory
Topics Stocks
Exposures US Equities
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results. 
Via Benzinga
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts
Via Benzinga
Peering Into Henry Schein's Recent Short Interest
Via Benzinga
Analyst Ratings For Henry Schein
Via Benzinga
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal
The private equity firm will also be able to purchase additional shares via open market purchases, up to a total equity stake of 14.9% in Henry Schein. 
Via Stocktwits
3 Value Stocks Amid “Unsustainable” Market Euphoria
Three value stocks that are well positioned to outperform in this overvalued market. 
Via Talk Markets
Topics Stocks / Equities
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential. 
Via Benzinga
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition. 
Via Benzinga
Where Henry Schein Stands With Analysts
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Henry Schein
Via Benzinga
Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises full-year EPS guidance upwards. 
Via Benzinga
HSIC Stock Earnings: Henry Schein Meets EPS, Misses Revenue for Q2 2024
HSIC stock results show that Henry Schein met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.